Conversion Securities. The Conversion Securities, when issued in accordance with the Terms and Conditions of the Bonds, shall be duly and validly issued, non-assessable and fully paid, and shall be free of any preemptive or similar rights or any Lien. Subject to the accuracy of the representations and warranties of the Investors in this Agreement and their compliance with the agreements set forth herein, the offer and issuance by the Company of the Bonds and the Conversion Securities issuable upon conversion thereof is exempt from registration under the Securities Act.
Appears in 1 contract
Sources: Convertible Bonds Subscription Agreement (Inovio Pharmaceuticals, Inc.)
Conversion Securities. The shares of the Company issuable upon conversion of the Bonds (the βConversion Securities, when issued in accordance with the Terms and Conditions of the Bonds, β) shall be duly and validly issued, non-assessable and fully paid, and shall be free of any preemptive or similar rights or any Lien. Subject to the accuracy of the representations and warranties of the Investors Investor in this Agreement and their compliance with the agreements set forth hereinAgreement, the offer and issuance by the Company of the Bonds and the Conversion Securities issuable upon conversion thereof is exempt from registration under the Securities Act.
Appears in 1 contract
Sources: Convertible Bonds Subscription Agreement (20/20 GeneSystems, Inc.)
Conversion Securities. The Conversion Securities, when issued in accordance with the Terms and Conditions of the Bonds, shall be duly and validly issued, non-assessable and fully paid, and shall be free of any preemptive or similar rights or any Lien. Subject to the accuracy of the representations and warranties of the Investors Investor in this Agreement and their compliance with the agreements set forth herein, the offer and issuance by the Company of the Bonds and the Conversion Securities issuable upon conversion thereof is exempt from registration under the Securities Act.
Appears in 1 contract
Sources: Convertible Bonds Subscription Agreement (Inovio Pharmaceuticals, Inc.)